id,title,publish_time,close_time,resolution,question_id,t,x
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 10:19:58.510105133,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 10:19:58.510105133,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 10:39:29.537632942,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 10:39:29.537632942,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 23:00:00.230487347,0.66
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 01:08:14.395836830,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 23:00:00.230487347,0.66
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 01:08:14.395836830,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 23:00:00.230487347,0.66
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 01:08:14.395836830,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 23:00:00.230487347,0.66
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 01:08:14.395836830,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 23:00:00.230487347,0.66
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 01:08:14.395836830,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:33:46.615589380,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:56:15.176309824,0.34
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:33:46.615589380,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:56:15.176309824,0.34
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:50:37.174201965,0.63
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:50:37.174201965,0.63
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:50:37.174201965,0.63
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:00.907862186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:08.125933886,0.23
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:00.907862186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:08.125933886,0.23
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:00.907862186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:08.125933886,0.23
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:00.907862186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:08.125933886,0.23
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:00.907862186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 21:05:08.125933886,0.23
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 03:29:26.985806227,0.28
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:03:40.658939838,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 05:16:05.059237719,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 05:16:05.059237719,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 15:26:35.133656979,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 19:54:42.728527546,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 10:01:57.046174288,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:02:16.943933725,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:02:16.943933725,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:02:16.943933725,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:06:59.793881893,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:06.461915731,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:18.122335196,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 01:18:31.125006676,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:06:59.793881893,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:06.461915731,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:18.122335196,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 01:18:31.125006676,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:06:59.793881893,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:06.461915731,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:18.122335196,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 01:18:31.125006676,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:06:59.793881893,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:06.461915731,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:18.122335196,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 01:18:31.125006676,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:06:59.793881893,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:06.461915731,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:50:18.122335196,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 01:18:31.125006676,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 19:08:53.245180130,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 19:08:53.245180130,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 07:29:43.282906294,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 07:29:43.282906294,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:37:44.201597452,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:37:44.201597452,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 19:14:29.754395247,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 06:33:20.316918135,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 06:33:20.316918135,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:43:56.256767988,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:43:56.256767988,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:43:56.256767988,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:43:56.256767988,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:43:56.256767988,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 19:20:59.875384808,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:48:06.059123993,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:08:27.091368198,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:25.335027695,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:40.192296505,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:48:06.059123993,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:08:27.091368198,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:25.335027695,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:40.192296505,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:48:06.059123993,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:08:27.091368198,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:25.335027695,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:40.192296505,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:48:06.059123993,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:08:27.091368198,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:25.335027695,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:09:40.192296505,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:55:51.793110847,0.8
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:55:51.793110847,0.8
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:55:51.793110847,0.8
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:55:51.793110847,0.8
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:55:51.793110847,0.8
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:55:51.793110847,0.8
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:11:38.575981855,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:04:45.937785864,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:11:38.575981855,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:04:45.937785864,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:11:38.575981855,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:04:45.937785864,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 08:01:54.422471762,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 19:55:32.740704775,0.99
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:22:57.878514528,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:03:25.671447992,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:22:57.878514528,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:03:25.671447992,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:22:57.878514528,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:03:25.671447992,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:22:57.878514528,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:03:25.671447992,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:22:57.878514528,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:03:25.671447992,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:22:57.878514528,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:03:25.671447992,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:22:57.878514528,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:03:25.671447992,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:26:20.074466228,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:26:20.074466228,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 21:26:20.074466228,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:07:21.671012878,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 04:12:42.591833353,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 01:56:32.097182274,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 07:19:16.116697311,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:07:21.671012878,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 04:12:42.591833353,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 01:56:32.097182274,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 07:19:16.116697311,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:07:21.671012878,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 04:12:42.591833353,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 01:56:32.097182274,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 07:19:16.116697311,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:07:21.671012878,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 04:12:42.591833353,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 01:56:32.097182274,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 07:19:16.116697311,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:07:21.671012878,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 04:12:42.591833353,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 01:56:32.097182274,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 07:19:16.116697311,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 18:40:03.876172543,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 17:21:20.486084700,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 17:21:20.486084700,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 17:21:20.486084700,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 17:21:20.486084700,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:05:34.674801826,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:05:34.674801826,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:05:34.674801826,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:05:34.674801826,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:05:34.674801826,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:05:34.674801826,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:35:20.076948404,0.67
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:36:20.929530382,0.14
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:36:29.646508455,0.14
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 18:23:16.771823883,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 19:44:28.645121813,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:35:20.076948404,0.67
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:36:20.929530382,0.14
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:36:29.646508455,0.14
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 18:23:16.771823883,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 19:44:28.645121813,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:41:54.285182476,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 12:26:50.181743860,0.11
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 18:23:32.847698212,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 14:09:28.617888927,0.69
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:35:44.053783178,0.77
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 21:14:47.036656141,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:29:36.496614456,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:41:54.285182476,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 12:26:50.181743860,0.11
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 18:23:32.847698212,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 14:09:28.617888927,0.69
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:35:44.053783178,0.77
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 21:14:47.036656141,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:29:36.496614456,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:41:54.285182476,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 12:26:50.181743860,0.11
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 18:23:32.847698212,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 14:09:28.617888927,0.69
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:35:44.053783178,0.77
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 21:14:47.036656141,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:29:36.496614456,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:41:54.285182476,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 12:26:50.181743860,0.11
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 18:23:32.847698212,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 14:09:28.617888927,0.69
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:35:44.053783178,0.77
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 21:14:47.036656141,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:29:36.496614456,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:41:54.285182476,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 12:26:50.181743860,0.11
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 18:23:32.847698212,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 14:09:28.617888927,0.69
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:35:44.053783178,0.77
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 21:14:47.036656141,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:29:36.496614456,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 20:41:54.285182476,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 12:26:50.181743860,0.11
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 18:23:32.847698212,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 14:09:28.617888927,0.69
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:35:44.053783178,0.77
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 21:14:47.036656141,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:29:36.496614456,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:47:05.321337700,0.79
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:47:05.321337700,0.79
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:57:21.100546598,0.31
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-20 23:57:21.100546598,0.31
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 14:45:29.881480694,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 05:32:02.807734013,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 22:15:57.300426722,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 22:15:57.300426722,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 22:15:57.300426722,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 22:15:57.300426722,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 22:15:57.300426722,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 23:22:10.754600525,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 23:22:10.754600525,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 03:04:18.196011543,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 03:04:18.196011543,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 03:04:18.196011543,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 03:04:18.196011543,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 03:04:18.196011543,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 03:04:18.196011543,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 03:04:18.196011543,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 08:06:29.153285027,0.03
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 17:05:22.776782990,0.08
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 17:05:27.258839129,0.08
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 08:06:29.153285027,0.03
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 17:05:22.776782990,0.08
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 17:05:27.258839129,0.08
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 08:06:29.153285027,0.03
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 17:05:22.776782990,0.08
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 17:05:27.258839129,0.08
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 15:01:06.616079807,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 15:01:06.616079807,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 04:28:30.489173651,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 04:28:30.489173651,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 04:28:30.489173651,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 04:28:30.489173651,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 04:28:30.489173651,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 04:28:30.489173651,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 04:28:30.489173651,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:17:07.318654537,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:17:07.318654537,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:20:32.453666925,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 06:39:09.786436796,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:33:18.376252651,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:34:12.926823378,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:20:32.453666925,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 06:39:09.786436796,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:33:18.376252651,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:34:12.926823378,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:20:32.453666925,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 06:39:09.786436796,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:33:18.376252651,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:34:12.926823378,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:20:32.453666925,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 06:39:09.786436796,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:33:18.376252651,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:34:12.926823378,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:20:32.453666925,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 06:39:09.786436796,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:33:18.376252651,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:34:12.926823378,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 04:20:32.453666925,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 06:39:09.786436796,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:33:18.376252651,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 02:34:12.926823378,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 17:17:32.861964226,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 17:17:40.527880429,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 17:17:32.861964226,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 17:17:40.527880429,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 05:34:37.764407158,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 15:38:27.944078445,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 15:57:10.249171019,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 15:57:10.249171019,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 07:26:19.091399193,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 07:26:19.091399193,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 07:26:19.091399193,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 07:26:19.091399193,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 07:26:19.091399193,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:18:09.590087652,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:18:09.590087652,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:24:58.996452570,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:31:05.022933006,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:24:58.996452570,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:31:05.022933006,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:13:01.993269205,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:13:56.384486914,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:13:01.993269205,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:13:56.384486914,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:50:06.057288408,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:55:12.112529993,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:55:12.112529993,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:55:12.112529993,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:55:12.112529993,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 08:55:12.112529993,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:26:20.919573069,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:26:20.919573069,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:26:20.919573069,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:26:20.919573069,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 18:26:20.919573069,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 09:54:54.010855436,0.75
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:12:16.325029612,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:12:16.325029612,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:32:50.298966885,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:32:50.298966885,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:42:03.723558664,0.99
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:42:03.723558664,0.99
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 18:06:25.114775658,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 15:12:43.593826056,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 15:54:57.221755505,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 04:28:11.912170410,0.55
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:29:58.598818064,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 15:54:57.221755505,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 04:28:11.912170410,0.55
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 05:29:58.598818064,0.33
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:37:03.367666960,0.02
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:43:29.643840075,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:43:35.994910955,0.03
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:37:03.367666960,0.02
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:43:29.643840075,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:43:35.994910955,0.03
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:37:03.367666960,0.02
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:43:29.643840075,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:43:35.994910955,0.03
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:02:22.273134708,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:02:22.273134708,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:02:22.273134708,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:02:22.273134708,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:02:22.273134708,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:48:30.419518471,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 19:48:34.179504395,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:26:51.575898886,0.51
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:26:51.575898886,0.51
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 16:26:51.575898886,0.51
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:05:37.761219263,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-25 20:05:37.761219263,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 08:24:43.331118107,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 08:24:43.331118107,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 08:24:43.331118107,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 08:24:43.331118107,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 08:24:43.331118107,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 08:24:43.331118107,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 17:32:00.697062492,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 17:32:00.697062492,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 17:32:00.697062492,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 17:32:00.697062492,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 18:15:32.405757666,0.32
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 18:20:10.708742857,0.04
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 19:36:50.681680202,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 18:38:25.522173405,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 21:14:00.830532074,0.99
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 21:15:56.141180515,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 21:15:56.141180515,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 21:15:56.141180515,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 21:15:56.141180515,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 21:15:56.141180515,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 04:26:36.792064428,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 05:15:38.669742107,0.68
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 05:15:45.534454345,0.68
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 05:15:38.669742107,0.68
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 05:15:45.534454345,0.68
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 06:10:02.432287931,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 16:00:00.590029716,0.24
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 06:10:02.432287931,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 16:00:00.590029716,0.24
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 06:10:02.432287931,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 16:00:00.590029716,0.24
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 06:10:02.432287931,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 16:00:00.590029716,0.24
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 06:10:02.432287931,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 16:00:00.590029716,0.24
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 06:10:02.432287931,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 16:00:00.590029716,0.24
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 09:41:15.556042910,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 09:16:41.124068260,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:58:50.217993736,0.32
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 09:41:15.556042910,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 09:16:41.124068260,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:58:50.217993736,0.32
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 09:41:18.010160208,0.8
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:53:02.464049101,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:53:02.464049101,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 10:53:02.464049101,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 00:07:55.459304333,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 23:29:07.964505672,0.22
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:01:19.516558170,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:02:32.457018614,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:33:14.233625889,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 23:30:59.316124439,0.41
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 00:04:05.316896677,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:27:00.486218452,0.52
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:44:08.126854897,0.59
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 16:53:52.227984190,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:38:23.165406704,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:41:05.815385103,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:00:58.479110479,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:01:14.443861246,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:32:24.003134966,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 00:07:55.459304333,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 23:29:07.964505672,0.22
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:01:19.516558170,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:02:32.457018614,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:33:14.233625889,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 23:30:59.316124439,0.41
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 00:04:05.316896677,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:27:00.486218452,0.52
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:44:08.126854897,0.59
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 16:53:52.227984190,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:38:23.165406704,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:41:05.815385103,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:00:58.479110479,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:01:14.443861246,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:32:24.003134966,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 00:07:55.459304333,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 23:29:07.964505672,0.22
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:01:19.516558170,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:02:32.457018614,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:33:14.233625889,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 23:30:59.316124439,0.41
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 00:04:05.316896677,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:27:00.486218452,0.52
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:44:08.126854897,0.59
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 16:53:52.227984190,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:38:23.165406704,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:41:05.815385103,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:00:58.479110479,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:01:14.443861246,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:32:24.003134966,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 00:07:55.459304333,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 23:29:07.964505672,0.22
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:01:19.516558170,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:02:32.457018614,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:33:14.233625889,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 23:30:59.316124439,0.41
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 00:04:05.316896677,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:27:00.486218452,0.52
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:44:08.126854897,0.59
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 16:53:52.227984190,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:38:23.165406704,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:41:05.815385103,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:00:58.479110479,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:01:14.443861246,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:32:24.003134966,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 00:07:55.459304333,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 23:29:07.964505672,0.22
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:01:19.516558170,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:02:32.457018614,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:33:14.233625889,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 23:30:59.316124439,0.41
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 00:04:05.316896677,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:27:00.486218452,0.52
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:44:08.126854897,0.59
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 16:53:52.227984190,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:38:23.165406704,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:41:05.815385103,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:00:58.479110479,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:01:14.443861246,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:32:24.003134966,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 00:07:55.459304333,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-21 23:29:07.964505672,0.22
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:01:19.516558170,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:02:32.457018614,0.45
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 13:33:14.233625889,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-22 23:30:59.316124439,0.41
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-23 00:04:05.316896677,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:27:00.486218452,0.52
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-24 19:44:08.126854897,0.59
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-26 16:53:52.227984190,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:38:23.165406704,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 12:41:05.815385103,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:00:58.479110479,0.58
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:01:14.443861246,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 12:32:24.003134966,0.6
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:52:38.850311995,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:58:05.796680689,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:52:38.850311995,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:58:05.796680689,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:52:38.850311995,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:58:05.796680689,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:52:38.850311995,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:58:05.796680689,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:52:38.850311995,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 16:58:05.796680689,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:01.211840153,0.97
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:17.334916115,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:01.211840153,0.97
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:17.334916115,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:01.211840153,0.97
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:17.334916115,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:01.211840153,0.97
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:17.334916115,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:01.211840153,0.97
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 17:35:17.334916115,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 18:58:28.176122189,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 18:58:28.176122189,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 19:33:20.515540837,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 19:33:20.515540837,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 19:33:20.515540837,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 19:45:08.900595665,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 20:56:53.338567257,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 20:56:53.338567257,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 21:26:08.262409449,0.19
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 21:27:27.077244997,0.23
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 22:14:29.396028042,0.12
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-27 22:14:29.396028042,0.12
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 03:09:33.963082552,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 03:32:46.498845577,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 03:32:46.498845577,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 03:51:32.660798311,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 03:51:32.660798311,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 03:51:32.660798311,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 04:00:17.360565186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 04:00:17.360565186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 04:00:17.360565186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 04:00:17.360565186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 04:00:17.360565186,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 05:33:15.276595831,0.21
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 05:33:15.276595831,0.21
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 05:33:15.276595831,0.21
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 05:33:15.276595831,0.21
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 05:33:15.276595831,0.21
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 07:15:12.888339758,0.99
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 08:49:04.131316422,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 09:06:29.496122360,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 08:49:04.131316422,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 09:06:29.496122360,0.9
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 09:35:17.386780977,0.32
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 09:35:17.386780977,0.32
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 09:35:17.386780977,0.32
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 09:35:17.386780977,0.32
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 13:49:03.478493690,0.41
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 17:11:30.012880564,0.05
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 17:11:39.474171638,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 19:15:14.274122238,0.03
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 19:49:35.547140837,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 20:31:29.631258011,0.38
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 21:16:40.697793722,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 04:36:45.122276545,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 21:16:40.697793722,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 04:36:45.122276545,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 21:25:49.802166462,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 21:25:49.802166462,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 21:25:49.802166462,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 21:25:49.802166462,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 21:25:49.802166462,0.61
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 23:39:21.159933329,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 23:39:50.871988535,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-28 23:44:13.767963886,0.36
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 00:13:53.139267683,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:30:33.579012156,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 00:13:53.139267683,0.5
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:30:33.579012156,0.35
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 02:55:20.844738007,0.29
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 02:55:20.844738007,0.29
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:56:19.107643843,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:57:39.926024199,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:56:19.107643843,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 06:57:39.926024199,0.65
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 08:15:17.871057510,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 08:15:17.871057510,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 09:34:02.365272045,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 10:32:13.595825195,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 09:34:02.365272045,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 10:32:13.595825195,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 09:34:02.365272045,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 10:32:13.595825195,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 13:07:43.427536726,0.15
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 14:14:44.555661201,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 14:14:44.555661201,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 14:14:44.555661201,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 19:57:32.535133839,0.25
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:36:38.209980726,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:36:38.209980726,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:36:38.209980726,0.44
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:37:02.579159021,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:37:02.579159021,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:37:02.579159021,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:37:02.579159021,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:37:02.579159021,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 20:37:02.579159021,0.27
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:29:22.499783516,0.21
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:29:22.499783516,0.21
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:36:17.829617977,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:36:17.829617977,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:36:17.829617977,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:36:17.829617977,0.1
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:47:04.880218267,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:51:40.001134872,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:47:04.880218267,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:51:40.001134872,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:47:04.880218267,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:51:40.001134872,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:47:04.880218267,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:51:40.001134872,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:47:04.880218267,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:51:40.001134872,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:47:04.880218267,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 22:51:40.001134872,0.2
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:06:08.876660824,0.37
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:12:11.008866549,0.51
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:14:33.672829866,0.49
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:12:11.008866549,0.51
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:14:33.672829866,0.49
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:32:24.424628019,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:44:43.847601652,0.18
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-29 23:44:43.847601652,0.18
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 00:33:04.256639719,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 00:33:04.256639719,0.4
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:06:52.314346552,0.37
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:06:52.314346552,0.37
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:06:52.314346552,0.37
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:06:52.314346552,0.37
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:06:52.314346552,0.37
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:57:29.097901583,0.36
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:57:29.097901583,0.36
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:57:29.097901583,0.36
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:57:29.097901583,0.36
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:57:29.097901583,0.36
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 01:57:29.097901583,0.36
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:15:50.997299194,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:15:50.997299194,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:15:50.997299194,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:15:50.997299194,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:15:50.997299194,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:15:50.997299194,0.71
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:56:52.865438461,0.14
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 02:57:17.385336637,0.01
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:01:12.946871042,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:01:12.946871042,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:01:12.946871042,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:01:12.946871042,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:01:12.946871042,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:01:12.946871042,0.3
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:15:35.310002804,0.07
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:34:29.904778481,0.07
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:15:35.310002804,0.07
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:34:29.904778481,0.07
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:38:11.750451565,0.76
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:38:11.750451565,0.76
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:38:11.750451565,0.76
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:38:11.750451565,0.76
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:38:11.750451565,0.76
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:38:11.750451565,0.76
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 03:38:11.750451565,0.76
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 04:20:14.320688725,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 04:20:14.320688725,0.7
5358,Will a SARS-CoV-2 vaccine candidate that has demonstrated an efficacy rate >75% in a n>500 RCT be administered to 10M people by March 1st 2021?,2020-10-20 00:00:00+02:00,2020-10-30 05:59:00+01:00,1.0,5358,2020-10-30 04:38:09.823485374,0.1
